secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001606498-23-000050
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos sells Respiratory Health to SunMed for $110M, accelerates portfolio focus
--------------------------------------------------------------------------------

- Definitive agreement to sell substantially all RH assets for $110M cash; close expected late 2023.
- Transaction includes BALLARD, MICROCUFF, endOclear brands and two manufacturing facilities in Mexico.
- Avanos will provide transition services; net proceeds enhance balance sheet for M&A in core categories.
- Divestiture is key component of three-year transformation to focus on Digestive Health and Pain Management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000050/0001606498-23-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000050/avns-20230607.htm
  HTML page:      https://secwatch.observer/filing/0001606498-23-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer